Delivery Order SPE2DR25D2022-SPE2DR26F2ZHD
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,571.73 for M-M-R II vaccine vials on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-competitive, firm fixed-price delivery order will be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award represents a small-value transaction under AmerisourceBergen's existing relationship with the federal government's medical supply chain. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,274.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of November 5, 2025. This firm fixed-price delivery order, issued on November 4, 2025, was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's critical role in supporting...
- The Defense Logistics Agency awarded a $11,180.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 26, 2025. This non-set-aside contract was awarded competitively on September 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,925.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 11, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, consistent with AmerisourceBergen's standard federal procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,797.70 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order, processed without a set-aside designation, represents a competitive procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,511.07 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This firm fixed price contract, issued on July 22, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,345.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as...
- The Defense Logistics Agency awarded a $4,685.90 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of M-M-R II vaccine vials. The contract utilizes firm fixed pricing with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials valued at $3,758.28 on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for M-M-R II vaccine vials, valued at $7,879.21. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2022Indefinite Delivery Contract
- SPE2DR25D2022-SPE2DR26F2ZHDDelivery Order
The Defense Logistics Agency awarded a delivery order for M-M-R II vaccine vials to AmerisourceBergen Drug Corp on November 4, 2025, with a ceiling value of $3,223.03 and an ultimate completion date of November 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement programs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, syringes, vials, and related medical commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's demonstrated capability in fulfilling federal medical supply requirements through open competition positions it as a key vendor within the DLA's pharmaceutical procurement network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 11/4/25 |